Pacira shareholders approve 2.5M share increase to equity plan; say-on-pay fails

Pacira BioSciences, Inc.

Stockholders approved Amended 2011 Plan adding 2,500,000 new shares for future grants.
Advisory say-on-pay resolution failed: 14,752,829 for, 22,595,202 against, 33,777 abstain.
Board will hold annual say-on-pay votes based on frequency vote (1 year: 35,312,982 votes).
Three Class II directors elected: Bigal, Lee, Young; no other director changes.
KPMG ratified as auditor for FY 2025 with 40,022,569 for, 352,947 against.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.